Email ID
Password
Sign me in automatically next time

About Us

SCRIP Intelligence is the leading source of news and strategic analysis for the global pharmaceutical industry. We filter the flood of information on the industry and apply the knowledge of our extensive network of analysts, journalists and key opinion leaders to provide our readers with timely business-critical market and competitor intelligence.

Our experienced writers and analysts are based in key geographic markets and cover all aspects of the industry – from small biotech start-ups to multinational giants, research boutiques to generic manufacturers. We focus on the whole of the drug discovery and development value chain and report on regulatory news, product approvals and rejections, and key corporate events.

In addition to our internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals. Owing to our high standing within the industry and the credibility of our writers, SCRIP Intelligence also enjoys privileged access to the industry's key thinkers and opinion leaders.

Editorial

Eleanor Malone
Editor
eleanor.malone@informa.com

+44 207 017 6976

Eleanor has been Editor of Scrip Intelligence since 2014. She has worked on the title since 2000, reporting and analysing all aspects of the global pharma industry from M&A and partnering, financial and strategy news and trends through R&D to market access, policy and regulation. She has also worked on Scrip’s sister publication Clinica Medtech Intelligence. She holds an MA in modern languages from the University of Edinburgh. Based in London, she appears regularly on TV and radio to discuss matters related to the industry.

SCRIP US team


Donna Young
Washington Editor
donna.young@informa.com

+1 301 216 2433
Donna covers all Washington biopharma-related daily news, regulatory, legislative and legal, and writes the weekly US Capitol Capsule column. Donna has covered healthcare policies, legislation, regulations and legal news from Washington for more than a decade. She has extensive knowledge of the FDA, the NIH and other federal agencies, including the Department of Homeland Security, the US Patent & Trademark Office and the Federal Trade Commission. Donna is very active on twitter - tweeting press conferences, government meetings and other live events. .

Mandy Jackson
West Coast Editor
mandy.jackson@informausa.com

+1 619 681 4631
Mandy Jackson is the US West Coast Editor for Scrip Intelligence. Her focus is US biotech and pharma, including financial, deal making and clinical trials news. Mandy has been a business news reporter for 15 years, covering biotech and pharma companies, biotech law and commercial real estate. She is based in San Diego, California.
SCRIP Asia team

Ian Haydock
Asia Editor
ian.haydock@informa.com

+81 042 259 1134
Ian is based in Tokyo and covers the Asian pharma markets for Scrip and its sister publication PharmAsia News (www.pharmasianews.com), of which he is managing editor. He writes about a broad range of business strategy and development, policy/regulatory and R&D issues relevant to both big pharma and smaller start-up firms, and has a particular interest in regulatory convergence initiatives in Asia. Ian has also covered of the Australian bioventure sector and aims to provide an analytical angle on major regional news.

Anju Ghangurde
South-East Asia Editor
Anju.Ghangurde@informa.com

+91 982 028 8667
Anju is responsible for reporting from India, a country that's oft described as the pharmacy of the world, and key South Asian markets. With close to a decade of previous experience in India's mainstream financial dailies, she writes extensively on a broad range of issues including competition and collaboration between generics and innovator firms, patent- related issues, drug pricing, the evolving regulatory and legal framework and company strategies.
SCRIP Europe team

Alexandra Shimmings
Managing Editor
alex.shimmings@informa.com

+44 207 017 6954

Alex has 19 years' experience in writing about the pharmaceutical industry, specialising in drug development, clinical trials and data.


Sukaina Virji
News Editor
sukaina.virji@informa.com

+44 203 377 3756
Sukaina has been covering the pharmaceutical and biotechnology space for Scrip for more than ten years, writing business, regulatory and clinical development news and analysis. Prior to working on Scrip, Suki was editor of BioVenture View newsletter and BioPeople magazine, publications which focused exclusively on the biotechnology sector, including financial and R&D news. She has a PhD in biochemistry and molecular biology from University College London..

John Hodgson
Data Editor
john.hodgson@informa.com

+44 203 377 3923

John has been a commentator and participant in biotechnology and life sciences research for over three decades as a writer and consultant. His focus has been on the use of deep data of all kinds to dispel market myths and redirect efforts in early commercial decision-making.


Francesca Bruce
Senior Reporter
francesca.bruce@informa.com

+44 207 017 5397
Francesca covers a range of policy and regulatory developments in Europe, with a focus on pricing and reimbursement and market access. In her role at Scrip she has also covered key emerging markets in Latin America, concentrating on Brazil, Mexico and Argentina.

Gemma Collier
Reporter
gemma.collier@informa.com

+44 203 377 3891
Gemma is a reporter on Scrip based in the UK. She covers a range of global news and analysis topics including people and appointments, clinical trial results, corporate financings, and marketing strategies including branding and social media.

Lucie Ellis
Creative Content Reporter
lucie.ellis@informa.com

+44 207 017 4417
Lucie joined the team in 2012 and is based in the UK. In her current role she covers news reporting, data visualisation projects for the Scrip website and handling of the weekly print issue. As a reporter Lucie covers a range of global news including: people and appointments; corporate financings and M&A activities; R&D news; and digital/social media development in the industry.

Analysts

Dr Peter Charlish
peter.charlish@informa.com
Peter focuses on drug discovery and product development, including clinical trials, and regulatory affairs, with knowledge extending across pharma, medical devices and diagnostics.

Ian Schofield
ian.schofield@informa.com
Ian writes on a wide range of issues affecting the pharmaceutical and biotech industry, with a focus on regulatory, political, legal and scientific affairs, mainly in Europe but also in Latin America and Russia. He has a particular interest in areas such as biosimilar regulation, new drug licensing pathways, pricing and reimbursement, clinical trial data transparency and the single European patent, and reports extensively on the activities of the EU institutions, including the European Medicines Agency, the European Commission and the European Parliament. Ian is also part of the team that operates the "Ask the Analyst" service for subscribers to Scrip and its sister publications.

Ashley Yeo
ashley.yeo@informa.com
Ashley has a wealth experience of the medical technology and healthcare sectors, focusing on healthcare and trade policy, business and financial performance and regulatory affairs. He was editor of Clinica for nine years until April 2009. He also contributes to In Vivo's medtech delivery as healthcare editor. 

Leadership

Mike Ward
Global Director of Content
mike.ward@informa.com
Mike has been writing, analysing and commenting on the life sciences industry for the past 30 years. He has focused on business models, R&D strategies and how to finance innovation, and is often called upon by the industry's key stakeholders to provide thought leadership. In 2010 he was named European Mediscience Commentator of the Year..

Phil Jarvis
Managing Director, Pharma News
phil.jarvis@informa.com
Phil is managing Director for Informa's Business Intelligence Pharma News group, which include Scrip Intelligence. Phil has over 15 years' experience in the world of B2B publishing covering the research-driven Crop Protection and Healthcare industries. Phil's ambition for the Scrip business is to serve the information and intelligence needs of pharma and biotech communities through the delivery of original, market-leading content.


Marketing & Customer Services
Farzana Sayani
Marketing Manager
farzana.sayani@informa.com
Dan Frere
Retention Team Leader
dan.frere@informa.com
New Subscriptions
+44 (0)20 7017 7572
sinead.greaney@informa.com
Customer Service Team
+44 (0)20 7017 4161
client.support@informa.com

To explore the complete range of pharma news, data and analysis that our subscribers enjoy every day, click on the button below to start your free trial.



EVENTS
22 April 2015
Silver Spring, MD
23 April 2015
1VS Westminster Conference Centre, 1 Victoria Street, London
JOB OF THE WEEK Promote your job vacancy
© 2015 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36